Warning letter
Medi-Fare Drug and Home Health Center: warning letter of Mar 7, 2013
FDA warning letter UCM343340 · Atlanta District Office
Key facts
| Reference number | UCM343340 |
|---|---|
| Company | Medi-Fare Drug and Home Health Center |
| Subject | CGMP for Finished Pharmaceutical/Unapproved New Drugs/Adulterated/Misbranded |
| Issue date | Mar 7, 2013 |
| Posted date | Mar 7, 2013 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 211.113(b), 201.115, 211, 211.28(a), 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.166(a), 211.167(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: